Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026)

Arcturus Therapeutics Holdings' (ARCT) quarterly Other Working Capital Changes came in at -$636000.0 in Q1 2026, up 93.52% YoY from -$328645.8 in Q1 2025, and up 96.93% on a QoQ basis from -$20.7 million in Q4 2025.

Analysis

Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026) Analysis & Trends

Arcturus Therapeutics Holdings (ARCT) has 9 years of Other Working Capital Changes data on file, last reported at -$636000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes rose 93.52% year-over-year to -$636000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.7 million (up 77.06% YoY) and the FY2025 annual result came in at -$23.9 million, up 56.76% from the prior year.
  • Other Working Capital Changes grew to -$636000.0 in Q1 2026, from -$20.7 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $4.2 million in Q3 2023 to a low of -$4.5 million in Q1 2023.
  • A 5-year average of -$55176.5 and a median of -$163000.0 in 2023 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 2236.52% — and 2023, when it surged 2424.27%.
  • Tracing ARCT's Other Working Capital Changes over 5 years: stood at -$11.2 million in 2022, then jumped by 141.41% to $4.6 million in 2023, then sank by 1231.1% to -$52.6 million in 2024, then jumped by 60.54% to -$20.7 million in 2025, then jumped by 96.93% to -$636000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$636000.0 (Q1 2026), -$20.7 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Arcturus Therapeutics Holdings 449.65 Mn 258.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.33 Mn
Jun 30, 2026 -1.33 Mn
Mar 31, 2026 -636,000.00
Mar 31, 2026 -636,000.00
Dec 31, 2025 -2.80 Mn
Dec 31, 2025 -2.80 Mn
Sep 30, 2025 -8.99 Mn
Sep 30, 2025 -8.99 Mn
Jun 30, 2025 -2.27 Mn
Jun 30, 2025 -2.27 Mn
Mar 31, 2025 -9.82 Mn
Mar 31, 2025 -9.82 Mn
Dec 31, 2024 -8.16 Mn
Dec 31, 2024 -8.16 Mn
Sep 30, 2024 -13.43 Mn
Sep 30, 2024 -13.43 Mn
Jun 30, 2024 -29.61 Mn
Jun 30, 2024 -29.61 Mn
Mar 31, 2024 -4.01 Mn
Mar 31, 2024 -4.01 Mn